We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

78 hedge funds and large institutions have $322M invested in Coherus Oncology in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 22

21% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 14

4% more funds holding

Funds holding: 75 → 78 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

26% less capital invested

Capital invested by funds: $434M → $322M (-$112M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.47M

Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
17
Increased
29
Reduced
22
Closed
14
Calls
–
Puts
$1.47M
Net Calls
-$1.47M
Net Calls Change
-$1.39M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.8M
2
NI
Numeric Investors
Massachusetts
+$6.15M
3
Fidelity International
Fidelity International
Bermuda
+$4.87M
4
BIT
BlackRock Institutional Trust
California
+$4.86M
5
CGI
CI Global Investments
California
+$4.56M

Top Sellers

Rank Fund Capital Flow
1
RSCM
Rock Springs Capital Management
Maryland
-$7.58M
2
PA
Perceptive Advisors
New York
-$7.48M
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.56M
4
Millennium Management
Millennium Management
New York
-$3.84M
5
RFC
Russell Frank Company
Washington
-$3.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
76
Simplex Trading
Illinois
$2K +$3.32K +109 New
Manulife (Manufacturers Life Insurance)
77
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$320 +$9.77K +321 +2%
PA
78
Perceptive Advisors
New York
– -$7.48M -258,716 Closed
CCMU
79
Cheyne Capital Management (UK)
United Kingdom
– -$2.45M -84,778 Closed
CS
80
Candriam SCA
Luxembourg
– -$1.16M -40,000 Closed
SM
81
Sabby Management
Florida
– -$867K -30,000 Closed
FAM
82
Fred Alger Management
New York
– -$723K -25,000 Closed
VOYA Investment Management
83
VOYA Investment Management
Georgia
– -$327K -11,331 Closed
CS
84
Credit Suisse
Switzerland
– -$284K -9,821 Closed
SIM
85
Spark Investment Management
New York
– -$270K -9,367 Closed
Citadel Advisors
86
Citadel Advisors
Florida
– -$212K -7,322 Closed
CIM
87
CIM Investment Management
Pennsylvania
– -$210K -7,277 Closed
UBS Group
88
UBS Group
Switzerland
– -$80K -2,777 Closed
Group One Trading
89
Group One Trading
Illinois
– -$61K -2,100 Closed
BRWM
90
B. Riley Wealth Management
Tennessee
– -$12K -434 Closed
Citigroup
91
Citigroup
New York
– -$10.7K -351 -98%
Invesco
92
Invesco
Georgia
– -$6K -197 Closed
1 2 3
4

CHRS Hedge Fund Activity: Q3 2015 in Review

78 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q3 2015, worth a combined $322M — down 26% from $434M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CHRS positions and 14 closed out — a net gain of 3 holders — while 29 added to existing stakes and 22 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $31.8M. The largest seller was Rock Springs Capital Management, cutting an estimated $7.58M.

  • 78 institutional investors held Coherus Oncology (CHRS) as of Q3 2015, up from 75 in Q2 2015.
  • Funds reported $322M of Coherus Oncology stock for Q3 2015, down 26% quarter-over-quarter.
  • 17 funds opened new Coherus Oncology positions in Q3 2015 and 14 closed out, a net change of +3 holders.
  • The largest Coherus Oncology buyer in Q3 2015 was Fidelity Investments, an estimated $31.8M added.
  • The largest Coherus Oncology seller in Q3 2015 was Rock Springs Capital Management, an estimated $7.58M sold.

Based on aggregated 13F filings for Q3 2015.